Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Genetics
Volume 2014 (2014), Article ID 691630, 4 pages
http://dx.doi.org/10.1155/2014/691630
Case Report

Complex Variant of Philadelphia Translocation Involving Chromosomes 9, 12, and 22 in a Case with Chronic Myeloid Leukaemia

1Research and Development, Cytogenetics and Molecular Biology, TOMA Advanced Biomedical Assays S.p.A., 25/27 Francesco Ferrer Street, 21052 Busto Arsizio, Varese, Italy
2Treviglio Caravaggio Hospital, 1 Pittori Cavenaghi Square, 24043 Caravaggio, Bergamo, Italy

Received 20 March 2014; Accepted 27 May 2014; Published 18 June 2014

Academic Editor: Gopalrao Velagaleti

Copyright © 2014 F. Malvestiti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. W. Vardiman, J. Thiele, D. A. Arber et al., “The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes,” Blood, vol. 114, no. 5, pp. 937–951, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Quintás-Cardama, H. Kantarjian, and J. Cortes, “Tyrosine kinase inhibitors for chronic myelogenous leukemia,” The New England Journal of Medicine, vol. 357, no. 15, pp. 1557–1558, 2007. View at Google Scholar · View at Scopus
  3. B. Johansson, T. Fioretos, and F. Mitelman, “Cytogenetic and molecular genetic evolution of chronic myeloid leukemia,” Acta Haematologica, vol. 107, no. 2, pp. 76–94, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. A. G. Reid, B. J. P. Huntly, C. Grace, A. R. Green, and E. P. Nacheva, “Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukaemia,” British Journal of Haematology, vol. 121, no. 3, pp. 419–427, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. M. M. T. El-Zimaity, H. Kantarjian, M. Talpaz et al., “Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome,” British Journal of Haematology, vol. 125, no. 2, pp. 187–195, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Babu and R. S. Verma, Human Chromosomes Principles and Techniques, McGraw Hill, Texas, Tex, USA, 2nd edition, 1995.
  7. “Citogenetica delle neoplasie oncoematolofiche,” http://www.sigu.net/.
  8. R. Hastings, R. Howell, D. Betts et al., Guidelines and Quality Assurance for Acquired Cytogenetics, E.C.A. European Cytogeneticists Association Newsletter No. 31, 2013, http://e-c-a.eu/files/downloads/NL31_Acquired_Guidelines.pdf.
  9. M. Baccarani, S. Pileri, J.-L. Steegmann, M. Muller, S. Soverini, and M. Dreyling, “Chronic myeloid leukemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up,” Annals of Oncology, vol. 23, no. 7, Article ID mds228, pp. vii72–vii77, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. L. G. Shaffer, J. McGowan-Jordan, and M. Schmid, International System for Human Cytogenetic Nomenclature, Karger, Basel, Switzerland, 2013.
  11. F. Albano, L. Anelli, A. Zagaria et al., “Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements,” Molecular Cancer, vol. 9, article 120, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Fisher, P. Strike, C. Scott, and A. V. Moorman, “Breakpoints of variant 9;22 translocations in chronic myeloid leukemia locate preferentially in the CG-richest regions of the genome,” Genes Chromosomes and Cancer, vol. 43, no. 4, pp. 383–389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Costa, A. Carrió, I. Madrigal et al., “Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia,” Cancer Genetics and Cytogenetics, vol. 166, no. 1, pp. 89–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Mitelman, B. Johansson, and F. Mertens, The Mitelman Database of Chromosome Aberrations in Cancer, http://www.cgap.nci.nih.gov/Chromosomes/Mitelman.
  15. Atlas of Chromosome in Cancer, http://atlasgeneticsoncology.org/index.html.
  16. OMIM, http://www.ncbi.nlm.nih.gov/omim/?term=OMIM.
  17. U. Bacher, T. Haferlach, W. Hiddemann, S. Schnittger, W. Kern, and C. Schoch, “Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression,” Cancer Genetics and Cytogenetics, vol. 157, no. 1, pp. 53–61, 2005. View at Publisher · View at Google Scholar · View at Scopus